Mithra Pharmaceuticals SA (0R91.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
As of 05:13PM BST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 15.59M |
| Enterprise value | 199.64M |
| Trailing P/E | N/A |
| Forward P/E | 2.53 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.20 |
| Price/book (mrq) | 4.80 |
| Enterprise value/revenue | 3.19 |
| Enterprise value/EBITDA | -151.24 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.73 |
| 52-week change 3 | -92.30% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 3.8500 |
| 52-week low 3 | 0.2040 |
| 50-day moving average 3 | 0.3589 |
| 200-day moving average 3 | 1.2608 |
Share statistics
| Avg vol (3-month) 3 | 14.36k |
| Avg vol (10-day) 3 | 11.1k |
| Shares outstanding 5 | 66.91M |
| Implied shares outstanding 6 | 84.1M |
| Float 8 | 42.87M |
| % held by insiders 1 | 31.02% |
| % held by institutions 1 | 12.67% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | -125.79% |
| Operating margin (ttm) | -62.11% |
Management effectiveness
| Return on assets (ttm) | -6.03% |
| Return on equity (ttm) | -575.59% |
Income statement
| Revenue (ttm) | 62.67M |
| Revenue per share (ttm) | 1.14 |
| Quarterly revenue growth (yoy) | -38.10% |
| Gross profit (ttm) | 47.37M |
| EBITDA | -32.98M |
| Net income avi to common (ttm) | -78.84M |
| Diluted EPS (ttm) | -1.4100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 23.71M |
| Total cash per share (mrq) | 0.35 |
| Total debt (mrq) | 306.72M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.04 |
| Book value per share (mrq) | -0.15 |
Cash flow statement
| Operating cash flow (ttm) | -9.38M |
| Levered free cash flow (ttm) | -24.96M |
© 2024 Yahoo. All rights reserved.